Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors
Novel technology based on epigenetic alterations could shorten wait for a definitive diagnosis in resource-poor settingsCredit: Wanjun Ding A team led by Johns Hopkins Kimmel...










